On the public citation graph
BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action
0 signed · 123 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1097-0142(197501)35:1<98::aid-cncr2820350115>3.0.co;2-bopenalex-snapshot
Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer
inferredcites →https://doi.org/10.1002/emmm.200900041openalex-snapshot
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
inferredcites →https://doi.org/10.1002/jps.2600751108openalex-snapshot
A Pharmacodynamic Model for the Activity of Antibiotics Against Microorganisms under Nonsaturable Conditions
inferredcites →https://doi.org/10.1002/pbc.22206openalex-snapshot
Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience
inferredcites →https://doi.org/10.1007/bf01062551openalex-snapshot
Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due toPseudomonas aeruginosa
inferredcites →https://doi.org/10.1007/s10549-008-0271-3openalex-snapshot
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells
inferredcites →https://doi.org/10.1016/0065-2571(84)90007-4openalex-snapshot
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
inferredcites →https://doi.org/10.1016/0169-4758(96)10055-7openalex-snapshot
Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria
inferredcites →https://doi.org/10.1016/j.canlet.2008.03.037openalex-snapshot
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
inferredcites →https://doi.org/10.1016/j.celrep.2014.09.028openalex-snapshot
Targeting the DNA Repair Pathway in Ewing Sarcoma
inferredcites →https://doi.org/10.1016/j.drudis.2006.11.008openalex-snapshot
Multi-target therapeutics: when the whole is greater than the sum of the parts
inferredcites →https://doi.org/10.1016/j.ijantimicag.2005.05.005openalex-snapshot
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1016/s0031-6997(25)06847-4openalex-snapshot
The search for synergy: a critical review from a response surface perspective.
inferredcites →https://doi.org/10.1016/s0163-7258(00)00086-3openalex-snapshot
Basis for effective combination cancer chemotherapy with antimetabolites
inferredcites →https://doi.org/10.1038/msb.2011.71openalex-snapshot
Systematic exploration of synergistic drug pairs
inferredcites →https://doi.org/10.1038/nature11005openalex-snapshot
Systematic identification of genomic markers of drug sensitivity in cancer cells
inferredcites →https://doi.org/10.1038/nrd3801openalex-snapshot
The determination and interpretation of the therapeutic index in drug development
inferredcites →https://doi.org/10.1038/nrmicro2239openalex-snapshot
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
inferredcites →https://doi.org/10.1038/nsmb.1915openalex-snapshot
Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination
inferredcites →https://doi.org/10.1074/jbc.m007807200openalex-snapshot
Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia
inferredcites →https://doi.org/10.1093/infdis/137.2.122openalex-snapshot
A Method for Testing for Synergy with Any Number of Agents
inferredcites →https://doi.org/10.1093/infdis/jiu603openalex-snapshot
Combination Treatment With Meropenem Plus Levofloxacin Is Synergistic Against Pseudomonas aeruginosa Infection in a Murine Model of Pneumonia
inferredcites →https://doi.org/10.1093/jac/dkg301openalex-snapshot
Synergy, antagonism, and what the chequerboard puts between them
inferredcites →https://doi.org/10.1097/00002030-200107270-00006openalex-snapshot
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults
inferredcites →https://doi.org/10.1097/00042560-200010010-00001openalex-snapshot
Strong in Vitro Synergy Between the Fusion Inhibitor T-20 and the CXCR4 Blocker AMD-3100
inferredcites →https://doi.org/10.1097/01.aids.0000247578.08449.ffopenalex-snapshot
An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults
inferredcites →https://doi.org/10.1109/tac.1974.1100705openalex-snapshot
A new look at the statistical model identification
inferredcites →https://doi.org/10.1111/j.1472-8206.2008.00633.xopenalex-snapshot
The Hill equation: a review of its capabilities in pharmacological modelling
inferredcites →https://doi.org/10.1111/j.1541-0420.2006.00579.xopenalex-snapshot
A Generalized Response Surface Model with Varying Relative Potency for Assessing Drug Interaction
inferredcites →https://doi.org/10.1111/j.1744-7348.1939.tb06990.xopenalex-snapshot
THE TOXICITY OF POISONS APPLIED JOINTLY1
inferredcites →https://doi.org/10.1124/pr.58.3.10openalex-snapshot
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
inferredcites →https://doi.org/10.1128/aac.00451-06openalex-snapshot
Combination Chemotherapy with the Nitroimidazopyran PA-824 and First-Line Drugs in a Murine Model of Tuberculosis
inferredcites →https://doi.org/10.1158/0008-5472.can-09-1947openalex-snapshot
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
inferredcites →https://doi.org/10.1158/0008-5472.can-11-3648openalex-snapshot
PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
inferredcites →https://doi.org/10.1158/0008-5472.can-14-3763openalex-snapshot
Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter
inferredcites →https://doi.org/10.1200/jco.1997.15.1.297openalex-snapshot
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
inferredcites →https://doi.org/10.1897/04-431r.1openalex-snapshot
Significance testing of synergistic/antagonistic, dose level-dependent, or dose ratio-dependent effects in mixture dose-response analysis
inferredcites →https://doi.org/10.2165/00003088-200544020-00005openalex-snapshot
Pharmacokinetic/Pharmacodynamic Modelling of Antibacterials In Vitro and In Vivo Using Bacterial Growth and Kill Kinetics
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9781119627784.ch14openalex-snapshot
Combination Therapy Case Studies in Anticancer and Anti‐Infectious Disease Drug Discovery and Development
inferred← citeshttps://doi.org/10.1002/prp2.1064openalex-snapshot
Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
inferred← citeshttps://doi.org/10.1002/ps.70164openalex-snapshot
Prediction of mixture toxicity of essential oil constituents using nonparametric and parametric models against Musca domestica L.
inferred← citeshttps://doi.org/10.1007/s10928-016-9490-0openalex-snapshot
Assessment of non-linear combination effect terms for drug–drug interactions
inferred← citeshttps://doi.org/10.1007/s43032-025-01941-4openalex-snapshot
Preventing Preterm Birth: The Search for Tocolytic Synergism
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.11569-7openalex-snapshot
Drug Combination Modeling
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104908openalex-snapshot
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
inferred← citeshttps://doi.org/10.1016/j.bbadis.2024.167625openalex-snapshot
ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.bmc.2022.117043openalex-snapshot
Multiple approaches to repurposing drugs for neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.canlet.2017.11.004openalex-snapshot
IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft
inferred← citeshttps://doi.org/10.1016/j.canlet.2018.10.033openalex-snapshot
Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations
inferred← citeshttps://doi.org/10.1016/j.ccell.2018.07.012openalex-snapshot
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses
inferred← citeshttps://doi.org/10.1016/j.ccell.2025.04.014openalex-snapshot
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target
inferred← citeshttps://doi.org/10.1016/j.cels.2019.01.003openalex-snapshot
Quantifying Drug Combination Synergy along Potency and Efficacy Axes
inferred← citeshttps://doi.org/10.1016/j.cels.2024.01.003openalex-snapshot
A continuous epistasis model for predicting growth rate given combinatorial variation in gene expression and environment
inferred← citeshttps://doi.org/10.1016/j.chembiol.2019.10.010openalex-snapshot
Antitubercular Triazines: Optimization and Intrabacterial Metabolism
inferred← citeshttps://doi.org/10.1016/j.chembiol.2020.04.002openalex-snapshot
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia
inferred← citeshttps://doi.org/10.1016/j.crphar.2022.100110openalex-snapshot
Evaluation of synergism in drug combinations and reference models for future orientations in oncology
inferred← citeshttps://doi.org/10.1016/j.dib.2021.107400openalex-snapshot
Data vignettes for the application of response surface models in drug combination analysis
inferred← citeshttps://doi.org/10.1016/j.drudis.2019.09.002openalex-snapshot
Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.06.002openalex-snapshot
Using response surface models to analyze drug combinations
inferred← citeshttps://doi.org/10.1016/j.drudis.2023.103625openalex-snapshot
The recent progress of deep-learning-based in silico prediction of drug combination
inferred← citeshttps://doi.org/10.1016/j.drudis.2025.104381openalex-snapshot
Synergism or mirage: Current progress and an empirical approach for elucidating combination drug effects
inferred← citeshttps://doi.org/10.1016/j.fbio.2024.103601openalex-snapshot
Virtual screening and multi-synergism of inhibitory compounds against pancreatic lipase
inferred← citeshttps://doi.org/10.1016/j.gpb.2022.01.004openalex-snapshot
SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
inferred← citeshttps://doi.org/10.1016/j.sjpain.2016.09.011openalex-snapshot
Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain
inferred← citeshttps://doi.org/10.1016/j.tips.2020.01.011openalex-snapshot
Charting the Fragmented Landscape of Drug Synergy
inferred← citeshttps://doi.org/10.1016/j.tube.2018.08.004openalex-snapshot
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase
inferred← citeshttps://doi.org/10.1038/s41419-026-08432-7openalex-snapshot
Targeting glycerophospholipid biosynthesis overcomes chemoresistance driven by SLFN11 loss in Ewing sarcoma
inferred← citeshttps://doi.org/10.1038/s41467-017-01929-yopenalex-snapshot
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions
inferred← citeshttps://doi.org/10.1038/s41467-021-24168-8openalex-snapshot
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
inferred← citeshttps://doi.org/10.1038/s41467-021-24789-zopenalex-snapshot
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery
inferred← citeshttps://doi.org/10.1038/s41467-023-36370-xopenalex-snapshot
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
inferred← citeshttps://doi.org/10.1038/s41467-024-48953-3openalex-snapshot
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
inferred← citeshttps://doi.org/10.1038/s41467-025-62618-9openalex-snapshot
Challenges to determine synergistic drug interactions in mice
inferred← citeshttps://doi.org/10.1038/s41564-025-02147-9openalex-snapshot
Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessus
inferred← citeshttps://doi.org/10.1038/s41598-017-18068-5openalex-snapshot
BIGL: Biochemically Intuitive Generalized Loewe null model for prediction of the expected combined effect compatible with partial agonism and antagonism
inferred← citeshttps://doi.org/10.1038/s41598-019-38907-xopenalex-snapshot
Comparison of null models for combination drug therapy reveals Hand model as biochemically most plausible
inferred← citeshttps://doi.org/10.1038/s41598-020-61923-1openalex-snapshot
A critical evaluation of methods to interpret drug combinations
inferred← citeshttps://doi.org/10.1038/s44386-024-00004-zopenalex-snapshot
Predicting drug combination response surfaces
inferred← citeshttps://doi.org/10.1073/pnas.2314101120openalex-snapshot
Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in Mycobacterium abscessus
inferred← citeshttps://doi.org/10.1080/14656566.2026.2660981openalex-snapshot
Phenotypic response surface-guided pharmacotherapy for personalized combination treatment in complex diseases
inferred← citeshttps://doi.org/10.1093/bib/bbaf099openalex-snapshot
Scaling up drug combination surface prediction
inferred← citeshttps://doi.org/10.1093/bioinformatics/btaa826openalex-snapshot
synergy: a Python library for calculating, analyzing and visualizing drug combination synergy
inferred← citeshttps://doi.org/10.1093/bioinformatics/btad240openalex-snapshot
SynBa: improved estimation of drug combination synergies with uncertainty quantification
inferred← citeshttps://doi.org/10.1093/bioinformatics/btz091openalex-snapshot
Response envelope analysis for quantitative evaluation of drug combinations
inferred← citeshttps://doi.org/10.1093/neuonc/noad064openalex-snapshot
ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma
inferred← citeshttps://doi.org/10.1093/neuonc/noae120openalex-snapshot
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors
inferred← citeshttps://doi.org/10.1093/neuped/wuaf018openalex-snapshot
Targeting the p53 pathway to treat atypical teratoid rhabdoid tumors
inferred← citeshttps://doi.org/10.1101/2020.04.25.061333openalex-snapshot
Repurposing Pyramax® for the Treatment of Ebola Virus Disease: Additivity of the Lysosomotropic Pyronaridine and Non-Lysosomotropic Artesunate
inferred← citeshttps://doi.org/10.1101/2020.12.06.407973openalex-snapshot
Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response
inferred← citeshttps://doi.org/10.1101/2023.07.14.549041openalex-snapshot
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
inferred← citeshttps://doi.org/10.1101/2025.05.09.652501openalex-snapshot
SLFN11 Loss-Induced Chemoresistance is Associated with Overexpression of Glycerophospholipid Biosynthesis in Ewing Sarcoma
inferred← citeshttps://doi.org/10.1101/683433openalex-snapshot
A Consensus Framework Unifies Multi-Drug Synergy Metrics
inferred← citeshttps://doi.org/10.1101/gr.210286.116openalex-snapshot
Detecting differential growth of microbial populations with Gaussian process regression
inferred← citeshttps://doi.org/10.1111/bcp.13986openalex-snapshot
Body of evidence and approaches applied in the clinical development programme of fixed‐dose combinations in the European Union from 2010 to 2016
inferred← citeshttps://doi.org/10.1111/cas.70042openalex-snapshot
The Combination of PARP and Topoisomerase 1 Inhibitors Improves Radiation Therapy for Ewing Sarcoma
inferred← citeshttps://doi.org/10.1124/pharmrev.124.000951openalex-snapshot
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-21-0896openalex-snapshot
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo
inferred← citeshttps://doi.org/10.1158/2767-9764.c.6893422.v1openalex-snapshot
Data from Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor Models
inferred← citeshttps://doi.org/10.1158/2767-9764.crc-23-0243openalex-snapshot
Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor Models
inferred← citeshttps://doi.org/10.1208/s12248-018-0226-5openalex-snapshot
Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug Combinations
inferred← citeshttps://doi.org/10.1208/s12248-019-0365-3openalex-snapshot
Optimizing Dose-Finding Studies for Drug Combinations Based on Exposure-Response Models
inferred← citeshttps://doi.org/10.1208/s12248-026-01214-1openalex-snapshot
Innovative In Vitro-In Silico Platform for Dose–Response Modeling in Canine Bladder Cancer: A 3D Organoid- and Mathematics-Based Approach
inferred← citeshttps://doi.org/10.1371/journal.pntd.0007890openalex-snapshot
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection
inferred← citeshttps://doi.org/10.1371/journal.pone.0296322openalex-snapshot
HTSplotter: An end-to-end data processing, analysis and visualisation tool for chemical and genetic in vitro perturbation screening
inferred← citeshttps://doi.org/10.18632/oncotarget.28551openalex-snapshot
ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines
inferred← citeshttps://doi.org/10.32614/cran.package.braidreportsopenalex-snapshot
braidReports: Visualize Combined Action Response Surfaces and Report BRAID Analyses
inferred← citeshttps://doi.org/10.32614/cran.package.braidrmopenalex-snapshot
braidrm: Fitting Combined Action with the BRAID Response Surface Model
inferred← citeshttps://doi.org/10.3324/haematol.2022.281443openalex-snapshot
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia
inferred← citeshttps://doi.org/10.33483/jfpau.1180259openalex-snapshot
SİNERJİSTİK İLAÇ KOMBİNASYONLARININ ANALİZİNDE GÜNCEL MATEMATİKSEL VE İSTATİSTİKSEL YÖNTEMLER
inferred← citeshttps://doi.org/10.3389/fmicb.2018.03196openalex-snapshot
Synergistic Impacts of Organic Acids and pH on Growth of Pseudomonas aeruginosa: A Comparison of Parametric and Bayesian Non-parametric Methods to Model Growth
inferred← citeshttps://doi.org/10.3389/fonc.2019.00875openalex-snapshot
Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples
inferred← citeshttps://doi.org/10.3390/cancers13061235openalex-snapshot
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma
inferred← citeshttps://doi.org/10.3390/ijms24119705openalex-snapshot
Mind the Curve: Dose–Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies
inferred← citeshttps://doi.org/10.3390/ijms27167491openalex-snapshot
Interactions Between Antioxidants: How Useful Are In Vitro Studies for Understanding the Action of Antioxidants in Complex Systems?
inferred← citeshttps://doi.org/10.7554/elife.73027openalex-snapshot
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
inferred← citeshttps://doi.org/10.7554/elife.89423openalex-snapshot
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
inferred← citeshttps://doi.org/10.7554/elife.89423.1openalex-snapshot
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
inferred← citeshttps://doi.org/10.7554/elife.89423.2openalex-snapshot
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
inferred← citeshttps://doi.org/10.7554/elife.89423.3openalex-snapshot
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.